Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics Европейски съюз - естонски - EMA (European Medicines Agency)

prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics

novartis vaccines and diagnostics s.r.l. - tüve a / viet nam / 1194/2004 (h5n1) gripiviiruse pinnaantigeenid (hemaglutiniin ja neuraminidaas) - influenza, human; immunization; disease outbreaks - vaktsiinid - aktiivne immuniseerimine gripiviiruse a viiruse h5n1 alatüübi vastu. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

Large Animal Immobilon süstelahus Естония - естонски - Ravimiamet

large animal immobilon süstelahus

novartis animal health inc. - etorfiin+atsepromasiin - süstelahus - 2,45mg+10mg 1ml 10.5ml 2tk

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) Европейски съюз - естонски - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptin, metformiin vesinikkloriid - suhkurtõbi, tüüp 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 ja 5. 1 erinevate kombinatsioonide kohta kättesaadavate andmete osas).

Tekturna Европейски съюз - естонски - EMA (European Medicines Agency)

tekturna

novartis europharm ltd. - aliskireen - hüpertensioon - reniini-angiotensiini süsteemi toimivad ained - essentsiaalse hüpertensiooni ravi.

THERAFLU SN siirup Естония - естонски - Ravimiamet

theraflu sn siirup

glaxosmithkline consumer healthcare (uk) trading limited - paratsetamool+pseudoefedriin - siirup - 500mg+30mg 30ml 240ml 1tk

LAMISIL nahasprei, lahus Естония - естонски - Ravimiamet

lamisil nahasprei, lahus

glaxosmithkline consumer healthcare (uk) trading limited - terbinafiin - nahasprei, lahus - 10mg 1g 15ml 1tk; 10mg 1g 30ml 1tk

THERAFLU siirup Естония - естонски - Ravimiamet

theraflu siirup

glaxosmithkline consumer healthcare (uk) trading limited - paratsetamool+guaifenesiin+fenüülefriin - siirup - 500mg+200mg+10mg 30ml 240ml 1tk

VENORUTON geel Естония - естонски - Ravimiamet

venoruton geel

glaxosmithkline consumer healthcare (uk) trading limited - rutosiid - geel - 20mg 1g 40g 1tk

Enviage Европейски съюз - естонски - EMA (European Medicines Agency)

enviage

novartis europharm ltd. - aliskireen - hüpertensioon - reniini-angiotensiini süsteemi toimivad ained - essentsiaalse hüpertensiooni ravi.

Imprida HCT Европейски съюз - естонски - EMA (European Medicines Agency)

imprida hct

novartis europharm ltd. - amlodipine, valsartan, hydrochlorothiazide - hüpertensioon - angiotensiin ii antagonistidega, tavaline, angiotensiin ii antagonistid, kombinatsioonid - essentsiaalse hüpertensiooni ravi täiskasvanud patsientidel, kellel on piisavat kombinatsioon amlodipiini, valsartaani ja hüdroklorotiasiidi (hct), kui kolm ühe komponendiga ravimvormid või nii asendusravi kui ka kahe komponendiga ja ühe komponendi koostise.